FI903827A0 - Foerfarande foer reducering av immunoglobulin e-responser. - Google Patents

Foerfarande foer reducering av immunoglobulin e-responser.

Info

Publication number
FI903827A0
FI903827A0 FI903827A FI903827A FI903827A0 FI 903827 A0 FI903827 A0 FI 903827A0 FI 903827 A FI903827 A FI 903827A FI 903827 A FI903827 A FI 903827A FI 903827 A0 FI903827 A0 FI 903827A0
Authority
FI
Finland
Prior art keywords
immunoglobulin
responser
foerfarande foer
antagonist
reducering
Prior art date
Application number
FI903827A
Other languages
English (en)
Finnish (fi)
Inventor
Robert L Coffman
Vries Jan Egbert De
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22538655&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI903827(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Publication of FI903827A0 publication Critical patent/FI903827A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI903827A 1988-02-02 1990-08-01 Foerfarande foer reducering av immunoglobulin e-responser. FI903827A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15141388A 1988-02-02 1988-02-02
PCT/US1989/000285 WO1989006975A1 (en) 1988-02-02 1989-01-30 Method of reducing immunoglobulin e responses

Publications (1)

Publication Number Publication Date
FI903827A0 true FI903827A0 (fi) 1990-08-01

Family

ID=22538655

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903827A FI903827A0 (fi) 1988-02-02 1990-08-01 Foerfarande foer reducering av immunoglobulin e-responser.

Country Status (20)

Country Link
US (1) US5676940A (ja)
EP (2) EP0327283B1 (ja)
JP (1) JPH03500050A (ja)
KR (1) KR900700132A (ja)
AT (1) ATE93144T1 (ja)
AU (1) AU629536B2 (ja)
CA (1) CA1341477C (ja)
DE (1) DE68908431T2 (ja)
DK (1) DK183590A (ja)
ES (1) ES2058490T3 (ja)
FI (1) FI903827A0 (ja)
HK (1) HK35196A (ja)
HU (1) HU211059B (ja)
IE (1) IE63097B1 (ja)
IL (1) IL89124A (ja)
MY (1) MY107079A (ja)
NZ (1) NZ227812A (ja)
PT (1) PT89573B (ja)
WO (1) WO1989006975A1 (ja)
ZA (1) ZA89766B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
DE69006221T2 (de) * 1989-12-04 1994-05-05 Fletcher Starnes H Verfahren zur behandlung von septischem schock.
IL96714A0 (en) * 1989-12-20 1991-09-16 Schering Corp Antibody antagonists of human interleukin-4
US5252677A (en) * 1990-11-20 1993-10-12 Mitsubishi Petrochemical Company Limited Functionalized olefin polymers
DE4137333A1 (de) * 1991-11-13 1993-05-19 W Prof Dr Sebald Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung
US5914110A (en) * 1993-09-07 1999-06-22 Smithkline Beecham Corporation Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5928904A (en) * 1993-09-07 1999-07-27 Smithkline Beecham Corporation DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US20020193575A1 (en) * 1993-09-07 2002-12-19 Smithkline Beecham P.L.C. Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5597710A (en) * 1994-03-10 1997-01-28 Schering Corporation Humanized monoclonal antibodies against human interleukin-4
US6919366B2 (en) 1998-05-22 2005-07-19 Avanir Pharmaceuticals Benzimidazole derivatives as modulators of IgE
US6911462B2 (en) 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
US6759425B2 (en) 1999-10-21 2004-07-06 Avanir Pharmaceuticals Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
DE16192152T1 (de) 2000-05-26 2020-08-06 Immunex Corporation Verwendung von interleukin-4 rezeptor (il-4r) antikörpern und zusammensetzungen davon
ATE369853T1 (de) 2001-03-12 2007-09-15 Avanir Pharmaceuticals Benzimidazolderivate zur ige-modulierung und zellproliferationshemmung
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
AR050044A1 (es) 2004-08-03 2006-09-20 Novartis Ag Anticuerpo especifico de il-4
US10196616B2 (en) 2017-02-15 2019-02-05 The United States Of America, As Represented By The Secretary Of Agriculture Altered avian virus for in-ovo inoculation and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
PT83761B (pt) * 1985-11-19 1989-06-30 Schering Biotech Corp Metodo para a producao de interleuquina-4 de mamifero
US5017691A (en) * 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
EP0255547A1 (en) * 1986-07-29 1988-02-10 Kishimoto, Tadamitsu, Prof. Monoclonal antibodies specific to surface receptor for IgE and hybrid cell lines producing these antibodies and use thereof
EP0407392B2 (en) * 1987-12-31 1998-10-28 Tanox Biosystems, Inc. UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES

Also Published As

Publication number Publication date
DK183590A (da) 1990-09-27
IE63097B1 (en) 1995-03-22
US5676940A (en) 1997-10-14
DK183590D0 (da) 1990-08-01
ES2058490T3 (es) 1994-11-01
HU891044D0 (en) 1990-11-28
PT89573A (pt) 1989-10-04
EP0397764A1 (en) 1990-11-22
DE68908431D1 (de) 1993-09-23
MY107079A (en) 1995-09-30
NZ227812A (en) 1991-09-25
IL89124A0 (en) 1989-08-15
EP0327283A1 (en) 1989-08-09
JPH03500050A (ja) 1991-01-10
PT89573B (pt) 1994-01-31
IL89124A (en) 1994-10-21
DE68908431T2 (de) 1993-12-23
AU3038389A (en) 1989-08-25
EP0327283B1 (en) 1993-08-18
KR900700132A (ko) 1990-08-11
ATE93144T1 (de) 1993-09-15
CA1341477C (en) 2005-03-29
ZA89766B (en) 1989-09-27
HU211059B (en) 1995-10-30
HK35196A (en) 1996-03-08
AU629536B2 (en) 1992-10-08
WO1989006975A1 (en) 1989-08-10
IE890302L (en) 1989-08-02
HUT54214A (en) 1991-01-28

Similar Documents

Publication Publication Date Title
FI903827A0 (fi) Foerfarande foer reducering av immunoglobulin e-responser.
NL300387I1 (nl) Antilichaam tegen menselijke interleukine-6-receptor
NO980030D0 (no) Monoklonale antistoffer som binder CD40-L
EE03285B1 (et) Immuunsust stimuleerivad monoklonaalsed antikehad
DK388384D0 (da) Monoklone antistoffer med specifitet for membran-associerede antigene, deres fremstilling og anvendelse
ES2062032T3 (es) Antagonista de interleuquina-5 para prevenir o reducir la eosinofilia.
ES2062762T3 (es) Metodo para tratar el choque septico.
FI924278A0 (fi) Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner.

Legal Events

Date Code Title Description
FC Application refused

Owner name: SCHERING BIOTECH CORPORATION